{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:09:26Z","timestamp":1770980966615,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.medcli.2017.04.023","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T09:31:12Z","timestamp":1497173472000},"page":"517-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["El polimorfismo TNF-\u03b1-308 determina las manifestaciones cl\u00ednicas y la respuesta al tratamiento de la espondilitis anquilosante en la etnia china Han"],"prefix":"10.1016","volume":"149","author":[{"given":"Hai-Jun","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Feng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.04.023_bib0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","article-title":"Pathogenesis of ankylosing spondylitis","volume":"6","author":"Tam","year":"2010","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0155","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","article-title":"Susceptibility to ankylosing spondylitis in twins: The role of genes, HLA, and the environment","volume":"40","author":"Brown","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.04.023_bib0160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1053\/berh.2002.0243","article-title":"Genetic aspects of ankylosing spondylitis","volume":"16","author":"Khan","year":"2002","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Braun","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.04.023_bib0170","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","volume":"18","author":"Maxwell","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.medcli.2017.04.023_bib0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00296-008-0671-z","article-title":"Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308G\/A polymorphism in promoter region of tumor necrosis factor: Association with distinct A33\/B58\/Cw10 haplotypes","volume":"29","author":"Lu","year":"2008","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.medcli.2017.04.023_bib0180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.humimm.2006.07.009","article-title":"Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis","volume":"67","author":"Vargas-Alarcon","year":"2006","journal-title":"Hum Immunol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0185","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.gene.6363701","article-title":"Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis","volume":"1","author":"Milicic","year":"2000","journal-title":"Genes Immun."},{"key":"10.1016\/j.medcli.2017.04.023_bib0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1749-6632.2009.04758.x","article-title":"Ankylosing spondylitis susceptibility and severity--contribution of TNF gene promoter polymorphisms at positions -238 and -308","volume":"1173","author":"Sousa","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.medcli.2017.04.023_bib0195","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/art.11106","article-title":"Identification of major loci controlling clinical manifestations of ankylosing spondylitis","volume":"48","author":"Brown","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.04.023_bib0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/kel175","article-title":"The 308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients","volume":"46","author":"Seitz","year":"2007","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.medcli.2017.04.023_bib0205","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2217\/pgs.13.146","article-title":"Association of TNF-alpha polymorphism with prediction of response to TNF blockers in spondyloarthritis and inflammatory bowel disease: A meta-analysis","volume":"14","author":"Tong","year":"2013","journal-title":"Pharmacogenomics."},{"key":"10.1016\/j.medcli.2017.04.023_bib0210","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2017.04.023_bib0215","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.62.6.519","article-title":"Radiographic assessment of sacroiliitis by radiologists and rheumatologists: Does training improve quality?","volume":"62","author":"Van Tubergen","year":"2003","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.04.023_bib0220","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.medcli.2017.04.023_bib0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","article-title":"Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product","volume":"1","author":"Wilson","year":"1992","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.medcli.2017.04.023_bib0230","first-page":"1110","article-title":"The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27","volume":"26","author":"McGarry","year":"1999","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1684\/ecn.2009.0143","article-title":"HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis","volume":"20","author":"Nicknam","year":"2009","journal-title":"Eur Cytokine Netw."},{"key":"10.1016\/j.medcli.2017.04.023_bib0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cyto.2012.09.007","article-title":"Association analysis of single nucleotide polymorphisms of proinflammatory cytokine and their receptors genes with rheumatoid arthritis in northwest Chinese Han population","volume":"61","author":"You","year":"2013","journal-title":"Cytokine."},{"key":"10.1016\/j.medcli.2017.04.023_bib0245","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3899\/jrheum.131315","article-title":"Tumor necrosis factor-alpha promoter-308\/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-alpha and does not predict TNF inhibitor response","volume":"41","author":"Nossent","year":"2014","journal-title":"J Rheumatol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00002281-200207000-00004","article-title":"Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis","volume":"14","author":"Brown","year":"2002","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbadis.2009.01.007","article-title":"Tumor necrosis factor alpha-308 gene locus promoter polymorphism: An analysis of association with health and disease","volume":"1792","author":"Elahi","year":"2009","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.medcli.2017.04.023_bib0260","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00586-011-1894-3","article-title":"Comparison of three types of lumbar osteotomy for ankylosing spondylitis: A case series and evolution of a safe technique for instrumented reduction","volume":"20","author":"Arun","year":"2011","journal-title":"Eur Spine J."},{"key":"10.1016\/j.medcli.2017.04.023_bib0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrrheum.2016.42","article-title":"New evidence on the management of spondyloarthritis","volume":"12","author":"Sieper","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/1744666X.2016.1218761","article-title":"An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis","volume":"13","author":"Osman","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.medcli.2017.04.023_bib0280","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/13102818.2014.972147","article-title":"Association of single nucleotide polymorphism at position -308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis","volume":"28","author":"Manolova","year":"2014","journal-title":"Biotechnol Biotechnol Equip."},{"key":"10.1016\/j.medcli.2017.04.023_bib0285","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/tpj.2015.49","article-title":"The -308 TNF\u03b1 and the -174 IL-6 promoter polymorphisms associate with effective anti-TNF\u03b1 treatment in seronegative spondyloarthritis","volume":"16","author":"Fabris","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.medcli.2017.04.023_bib0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/FPC.0000000000000085","article-title":"Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis","volume":"24","author":"Zhang","year":"2014","journal-title":"Pharmacogenet Genomics."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317303597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317303597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:44:29Z","timestamp":1635486269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317303597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0025775317303597"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.04.023","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"El polimorfismo TNF-\u03b1-308 determina las manifestaciones cl\u00ednicas y la respuesta al tratamiento de la espondilitis anquilosante en la etnia china Han","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}